Physician profile
David Jon Stroh
NPI 1144286212
$2,455.04
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,337 · 2020: $650 · 2021: $18.11 · 2024: $450.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $450.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $449.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $493.92 | 2019-2020 | |
| Stryker Corporation | $449.74 | 2024 | Pro |
| Sanofi-Aventis U.S. LLC | $214.26 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $212.33 | 2019-2021 | |
| Astellas Pharma US INC | $207.04 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $182.36 | 2019-2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $173.28 | 2019-2020 | |
| Astrazeneca Pharmaceuticals Lp | $139.57 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $107.12 | 2019-2020 | |
| Pfizer INC. | $90.44 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $59.54 | 2019-2020 | |
| Abbott Laboratories | $43.48 | 2019-2020 | |
| Boston Scientific Corporation | $34.85 | 2019-2020 | |
| Bardy Diagnostics, INC. | $20.00 | 2019 | |
| Amarin Pharma, INC. | $15.74 | 2020 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alnylam Pharmaceuticals INC. | $11.37 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Stroh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.